| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3696996
Max Phase: Preclinical
Molecular Formula: C19H18F3N3O5
Molecular Weight: 425.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CNC(=O)C(C(=O)NO)N(C)C(=O)c1ccc(-c2ccc(OC(F)(F)F)cc2)cc1
Standard InChI: InChI=1S/C19H18F3N3O5/c1-23-16(26)15(17(27)24-29)25(2)18(28)13-5-3-11(4-6-13)12-7-9-14(10-8-12)30-19(20,21)22/h3-10,15,29H,1-2H3,(H,23,26)(H,24,27)
Standard InChI Key: DHPGAHWEAGEKGM-UHFFFAOYSA-N
Associated Targets(non-human)
UDP-3-O-acyl-GlcNAc deacetylase 700 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 425.36 | Molecular Weight (Monoisotopic): 425.1199 | AlogP: 1.94 | #Rotatable Bonds: 6 |
| Polar Surface Area: 107.97 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.64 | CX Basic pKa: | CX LogP: 2.43 | CX LogD: 2.40 |
| Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.37 | Np Likeness Score: -0.74 |
References
| 1. (2015) Hydroxamic acid derivative, |
Source
Source(1):